Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Chronic hepatitis B virus (HBV) infection, which ultimately leads to liver cirrhosis, hepatic decompensation, and hepatocellular 1073spx carcinoma (HCC), remains a significant disease burden worldwide.Despite the use of antiviral therapy (AVT) using oral nucleos(t)ide analogs (NUCs) with high genetic barriers, the risk of HCC development cannot be